General Information of the Compound
Compound ID |
CP0574174
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]-N-[8-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-2-oxoethyl]amino]octyl]propanamide
Show/Hide
|
||||||||||||||||||
Formula |
C54H69ClN10O9S
|
||||||||||||||||||
Molecular Weight |
1069.727
|
||||||||||||||||||
Canonical SMILES |
CC(C)Oc1cc(C2CCN(CCC(=O)NCCCCCCCCNCC(=O)Nc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C54H69ClN10O9S/c1-33(2)74-44-30-38(35(5)29-42(44)61-54-58-31-39(55)50(63-54)60-40-16-10-11-18-45(40)75(72,73)34(3)4)36-21-26-64(27-22-36)28-23-46(66)57-25-13-9-7-6-8-12-24-56-32-48(68)59-41-17-14-15-37-49(41)53(71)65(52(37)70)43-19-20-47(67)62-51(43)69/h10-11,14-18,29-31,33-34,36,43,56H,6-9,12-13,19-28,32H2,1-5H3,(H,57,66)(H,59,68)(H,62,67,69)(H2,58,60,61,63)
Show/Hide
|
||||||||||||||||||
InChIKey |
ATCFOXIBVDCOLC-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound